Skip To The Main Content
Marisa Geiger
 

Marisa Geiger

Partner
 
425 Lexington Avenue
New York, NY 10017 
 
Email:
Fax: +1-212-455-2502

Marisa Geiger, a Partner in the Intellectual Property Practice and Privacy and Cybersecurity Practice, has been recognized among leading lawyers advising on intellectual property matters and technology transactions by Chambers USA and Legal 500 USA. Marisa advises clients on the IP and technology aspects of complex corporate transactions, including mergers and acquisitions, divestitures, carve outs, minority investments and spin-offs, and the structuring and negotiation of complex, standalone IP transactions, including in the context of strategic alliances and joint ventures, collaboration and development agreements, license agreements, long-term services agreements and distribution agreements. Marisa provides broad-based counseling services covering IP and privacy and cybersecurity matters to clients in a variety of industries. She has also advised on the successful resolution of a wide range of IP disputes.

Read Full Biography...

Work Highlights

Representative experience prior to joining Simpson Thacher includes advising:

  • The Blackstone Group in its acquisition of a majority stake in ZO Skin Health, Inc.
  • Eli Lilly and Company in its $1 billion acquisition of Prevail Therapeutics Inc. and its global exclusive licensing and research collaboration with, and equity investment in, Precision Biosciences, Inc.
  • General Electric in the separation and spin-off of its health care business, launching GE HealthCare Technologies Inc. as a publicly traded company on the Nasdaq
  • Softbank Vision Fund in its $2.25 billion minority investment in GM Cruise Holdings LLC and its $500 million minority investment in Cambridge Mobile Telematics, Inc.
  • Yahoo! Inc. in its strategic acquisitions of, or asset acquisitions from, 16 different companies; $4.5 billion sale of its operating business to Verizon Communications Inc.; 30-year exclusive commercial agreement with Taboola; and sale of Edgecast, Inc. to Limelight Networks, Inc.
  • Qualcomm Inc. in its $4.5 billion all-cash acquisition, alongside SSW Partners, of Veoneer, Inc. 
Accolades
  • Recommended for Patents: Licensing by Legal 500 USA and IT & Outsourcing: Transactions (New York) (2021)
  • Named “Associate to Watch” in IT & Outsourcing: Transactions (New York) by Chambers USA (2019)
Education
  • University of Pennsylvania Carey Law School, 2010 J.D.
  • University of Pennsylvania, 2005 B.A.
    magna cum laude
Admissions
  • New York 2012
  • California 2017

Based in the New York office, Marisa B. Geiger is a Partner in the Firm’s Intellectual Property Practice and Privacy and Cybersecurity Practice. Recognized among leading lawyers advising on intellectual property matters and technology transactions by Chambers USA and Legal 500 USA, Marisa advises on the IP and technology aspects of complex corporate transactions, including mergers and acquisitions, divestitures, carve outs, minority investments and spin-offs, and the structuring and negotiation of complex, standalone IP transactions, including in the context of strategic alliances and joint ventures, collaboration and development agreements, license agreements, long-term services agreements and distribution agreements. She provides broad-based counseling services covering IP and privacy and cybersecurity matters to clients in a variety of industries, including internet, telecommunications, social and digital media, software, hardware, pharmaceuticals, biotechnology, digital health, health services, content, retail, manufacturing, transportation and consumer products. She has also advised on the successful resolution of a wide range of IP disputes.

Prior to joining Simpson Thacher, in addition to negotiating high-profile settlements of worldwide IP disputes and confidential licensing, collaboration and development arrangements, Marisa provided counsel on the IP and technology components of numerous corporate transactions.

Representative experience prior to joining Simpson Thacher includes advising:

  • Funds managed by affiliates of Apollo Global Management, Inc. in their all-cash, take-private acquisition of Arconic Corporation, a leading provider of aluminum sheet, plate and extrusions, for approximately $5.2 billion
  • Aptiv PLC, a global technology company, in its $3.5 billion acquisition of Wind River, a global leader in delivering software for the intelligent edge
  • The Blackstone Group in its acquisition of a majority stake in ZO Skin Health, Inc., a premium California-based professional skincare brand
  • CLS Behring LLC, a global biotherapeutics company, in its up to $416 million acquisition of Calimmune, Inc., a privately held biotechnology company focused on the development of ex vivo ematopoietic stem cell (HSC) gene therapy
  • Centerbridge Partners, L.P. as lead investor in a $700 million private financing of Sabre Corporation, a leading software and technology provider that powers the global travel industry
  • Eli Lilly and Company, a global pharmaceutical company, in its
    • $1 billion acquisition of gene therapy company Prevail Therapeutics Inc; and
    • a global exclusive licensing and research collaboration with, and equity investment in, clinical stage biotech company Precision Biosciences, Inc.
  • EQT Partners’ Infrastructure IV fund in its acquisition of Lazer Logistics, North America’s largest provider of outsourced yard management and trailer spotting services
  • Facebook, Inc. (now Meta Platforms, Inc.) in its $19 billion acquisition of WhatsApp, a mobile messaging service
  • General Electric Company in the separation and spin-off of its health care business, launching GE HealthCare Technologies Inc., a global leader in precision health care, as a publicly traded company on the Nasdaq
  • Genstar Capital in its
    • acquisition of Power Products Holdings LLC, a supplier and manufacturer of a diversified portfolio of branded aftermarket electrical systems and components;
    • sales of Boyd Corporation, ConvergeOne Holdings Corp. and Tecomet Inc; and
    • $910 million sale of the Global Marine and Mobile business of Power Products Holdings LLC
  • GLOBALFOUNDRIES in its
    • acquisition of IBM's semiconductor technology business; and 
    • sale of its Application Specific Integrated Circuit (ASIC) business to Avera Semiconductor
  • Koshidaka Holdings Co., Ltd. in the U.S. aspects of its acquisition of Curves and Curves for Women II, L.C.
  • Magellan Health, Inc., a Fortune 500 company and leading provider of healthcare services, in its $2.2 billion merger with Centene Corporation
  • McGraw-Hill Companies in the divestiture of its education business to funds affiliated with Apollo Global Management, LLC for $2.5 billion
  • Merz North America, Inc., a specialty healthcare company with focuses on aesthetics, dermatology and neurosciences, in its
    • $600 million acquisition of Ulthera, a global medical device company that commercializes an FDA-approved therapeutic ultrasound platform technology used for non-surgical skin lifts; and
    • acquisition of On Light Sciences, Inc., a U.S. based medical device company that focuses on laser-based dermatologic procedures
  • Providence Equity Partners, a global private equity firm, in its
    • acquisition of a majority stake in 365 Retail Markets LLC, a provider of end-to-end integrated SaaS software, payment processing and point of-sale hardware for the foodservice industry; and
    • $635 million sale of Decision Resources, Inc., a provider of research, predictive analytics and consulting services to the healthcare industry
  • Qualcomm Inc. in its $4.5 billion all-cash acquisition, alongside SSW Partners, of Veoneer, Inc., a Stockholm-based global automotive technology leader
  • Quest Diagnostics Inc., a leading provider of diagnostic testing and information services, in its acquisitions of
    • the U.S. laboratory services business of Oxford Immunotec Global PLCL, along with an associated long term supply arrangement for T-SPOT.TB test kits and related accessories; and
    • Blueprint Genetics, a specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics
  • Softbank Vision Fund in its
    • $2.25 billion minority investment in GM Cruise Holdings LLC (Cruise), a U.S.-based autonomous driving vehicle company, alongside a $1.1 billion investment in Cruise by GM;
    • $500 million minority investment in Cambridge Mobile Telematics, Inc., a mobile telematics and analytics provider
  • Thomas H. Lee Partners in its $1.1 billion acquisition of CompuCom, an IT services and solutions specialist
  • Twilio Inc., a cloud communications platform company, in its acquisition of Authy, Inc., a privately owned company that provides two-factor authentication services to end users, developers and enterprises
  • Yahoo! Inc. in its
    • strategic acquisitions of, or asset acquisitions from, Tumblr, Inc., BrightRoll, Inc., Summly Limited, Flurry, Inc., MSKYNET, ThumbsUp Labs, Tomfoolery, Xobni Corporation, Snip.it, UrbanQ, GhostBird Software, Inc., AdMovate, Inc., Hitpost, Cooliris, PTCH and Wagr;
    • $4.5 billion sale of its operating business to Verizon Communications Inc.;
    • 30-year exclusive commercial agreement with Taboola; and
    • sale of Edgecast, Inc. to Limelight Networks, Inc.

In 2014, Marisa was seconded under the head of the IP Transaction Group at Yahoo! Inc. She also served as a voting member on the IP Licensing Standards Committee of the Licensing Executives Society of USA and Canada from 2020-2021.

Marisa received her J.D. from the University of Pennsylvania Law School and a B.A., magna cum laude, from the University of Pennsylvania. She is admitted to practice in New York and California.

News & Events

    Publications